Global Recombinant Vaccines Market Insights, Forecast to 2025

Publisher Name :
Date: 17-Jun-2019
No. of pages: 111
Inquire Before Buying

Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.

These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.

Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.

There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.

The global Recombinant Vaccines market is valued at 880 million US$ in 2018 and will reach 1400 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Recombinant Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Vaccines in these regions.

This research report categorizes the global Recombinant Vaccines market by top players/brands, region, type and end user. This report also studies the global Recombinant Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Merck & Co., Inc

- Green Cross Corporation

- Pfizer Inc.

- Bayer AG

- Sanofi S A.

- Protein Science Corporation

- GlaxoSmithKline Plc.

- Novartis AG

- Bharat Biotech

Market size by Product

- Subunit Recombinant Vaccines

- Attenuated Recombinant Vaccines

- Vector Recombinant Vaccines

Market size by End User

- Recombinant Human Vaccines

- Animal Recombinant Vaccines

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Recombinant Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Recombinant Vaccines market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Recombinant Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Recombinant Vaccines submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Vaccines are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Recombinant Vaccines Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Recombinant Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Recombinant Vaccines Market Size Growth Rate by Product
1.4.2 Subunit Recombinant Vaccines
1.4.3 Attenuated Recombinant Vaccines
1.4.4 Vector Recombinant Vaccines
1.5 Market by End User
1.5.1 Global Recombinant Vaccines Market Size Growth Rate by End User
1.5.2 Recombinant Human Vaccines
1.5.3 Animal Recombinant Vaccines
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Recombinant Vaccines Market Size
2.1.1 Global Recombinant Vaccines Revenue 2014-2025
2.1.2 Global Recombinant Vaccines Sales 2014-2025
2.2 Recombinant Vaccines Growth Rate by Regions
2.2.1 Global Recombinant Vaccines Sales by Regions
2.2.2 Global Recombinant Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Recombinant Vaccines Sales by Manufacturers
3.1.1 Recombinant Vaccines Sales by Manufacturers
3.1.2 Recombinant Vaccines Sales Market Share by Manufacturers
3.1.3 Global Recombinant Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Recombinant Vaccines Revenue by Manufacturers
3.2.1 Recombinant Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Recombinant Vaccines Price by Manufacturers
3.4 Recombinant Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Recombinant Vaccines Sales by Product
4.2 Global Recombinant Vaccines Revenue by Product
4.3 Recombinant Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Recombinant Vaccines Breakdown Data by End User
6 North America
6.1 North America Recombinant Vaccines by Countries
6.1.1 North America Recombinant Vaccines Sales by Countries
6.1.2 North America Recombinant Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Recombinant Vaccines by Product
6.3 North America Recombinant Vaccines by End User
7 Europe
7.1 Europe Recombinant Vaccines by Countries
7.1.1 Europe Recombinant Vaccines Sales by Countries
7.1.2 Europe Recombinant Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Vaccines by Product
7.3 Europe Recombinant Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Recombinant Vaccines by Countries
8.1.1 Asia Pacific Recombinant Vaccines Sales by Countries
8.1.2 Asia Pacific Recombinant Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Recombinant Vaccines by Product
8.3 Asia Pacific Recombinant Vaccines by End User
9 Central & South America
9.1 Central & South America Recombinant Vaccines by Countries
9.1.1 Central & South America Recombinant Vaccines Sales by Countries
9.1.2 Central & South America Recombinant Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Recombinant Vaccines by Product
9.3 Central & South America Recombinant Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Vaccines by Countries
10.1.1 Middle East and Africa Recombinant Vaccines Sales by Countries
10.1.2 Middle East and Africa Recombinant Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Recombinant Vaccines by Product
10.3 Middle East and Africa Recombinant Vaccines by End User
11 Company Profiles
11.1 Merck & Co., Inc
11.1.1 Merck & Co., Inc Company Details
11.1.2 Company Business Overview
11.1.3 Merck & Co., Inc Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck & Co., Inc Recombinant Vaccines Products Offered
11.1.5 Merck & Co., Inc Recent Development
11.2 Green Cross Corporation
11.2.1 Green Cross Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Green Cross Corporation Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Green Cross Corporation Recombinant Vaccines Products Offered
11.2.5 Green Cross Corporation Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Inc. Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Inc. Recombinant Vaccines Products Offered
11.3.5 Pfizer Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Company Business Overview
11.4.3 Bayer AG Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bayer AG Recombinant Vaccines Products Offered
11.4.5 Bayer AG Recent Development
11.5 Sanofi S A.
11.5.1 Sanofi S A. Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi S A. Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanofi S A. Recombinant Vaccines Products Offered
11.5.5 Sanofi S A. Recent Development
11.6 Protein Science Corporation
11.6.1 Protein Science Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Protein Science Corporation Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Protein Science Corporation Recombinant Vaccines Products Offered
11.6.5 Protein Science Corporation Recent Development
11.7 GlaxoSmithKline Plc.
11.7.1 GlaxoSmithKline Plc. Company Details
11.7.2 Company Business Overview
11.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Products Offered
11.7.5 GlaxoSmithKline Plc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Company Business Overview
11.8.3 Novartis AG Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis AG Recombinant Vaccines Products Offered
11.8.5 Novartis AG Recent Development
11.9 Bharat Biotech
11.9.1 Bharat Biotech Company Details
11.9.2 Company Business Overview
11.9.3 Bharat Biotech Recombinant Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bharat Biotech Recombinant Vaccines Products Offered
11.9.5 Bharat Biotech Recent Development
12 Future Forecast
12.1 Recombinant Vaccines Market Forecast by Regions
12.1.1 Global Recombinant Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Recombinant Vaccines Revenue Forecast by Regions 2019-2025
12.2 Recombinant Vaccines Market Forecast by Product
12.2.1 Global Recombinant Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Recombinant Vaccines Revenue Forecast by Product 2019-2025
12.3 Recombinant Vaccines Market Forecast by End User
12.4 North America Recombinant Vaccines Forecast
12.5 Europe Recombinant Vaccines Forecast
12.6 Asia Pacific Recombinant Vaccines Forecast
12.7 Central & South America Recombinant Vaccines Forecast
12.8 Middle East and Africa Recombinant Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Recombinant Vaccines Product Picture
Table Recombinant Vaccines Market Segments
Table Key Manufacturers Recombinant Vaccines Covered
Table Global Recombinant Vaccines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Recombinant Vaccines Sales Market Share by Product 2014-2025
Figure Subunit Recombinant Vaccines Product Picture
Table Major Manufacturers of Subunit Recombinant Vaccines
Figure Attenuated Recombinant Vaccines Product Picture
Table Major Manufacturers of Attenuated Recombinant Vaccines
Figure Vector Recombinant Vaccines Product Picture
Table Major Manufacturers of Vector Recombinant Vaccines
Table Global Recombinant Vaccines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Recombinant Human Vaccines
Figure Animal Recombinant Vaccines
Figure Recombinant Vaccines Report Years Considered
Figure Global Recombinant Vaccines Market Size 2014-2025 (Million US$)
Figure Global Recombinant Vaccines Sales 2014-2025 (K Units)
Table Global Recombinant Vaccines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Recombinant Vaccines Sales by Regions 2014-2019 (K Units)
Table Global Recombinant Vaccines Sales Market Share by Regions 2014-2019
Figure Global Recombinant Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Vaccines Sales Market Share by Regions
Table Global Recombinant Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Recombinant Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Vaccines Revenue Market Share by Regions
Table Global Recombinant Vaccines Sales by Manufacturers (2014-2019) (K Units)
Table Global Recombinant Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Recombinant Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Recombinant Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Recombinant Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Recombinant Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Recombinant Vaccines Price (2014-2019) (USD/Unit)
Table Recombinant Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Recombinant Vaccines Product Type
Table Date of International Manufacturers Enter into Recombinant Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Vaccines Sales by Product (2014-2019) (K Units)
Table Global Recombinant Vaccines Sales Share by Product (2014-2019)
Figure Global Recombinant Vaccines Sales Market Share by Product (2014-2019)
Figure Global Recombinant Vaccines Sales Market Share by Product in 2018
Table Global Recombinant Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Recombinant Vaccines Revenue Share by Product (2014-2019)
Figure Global Recombinant Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Recombinant Vaccines Revenue Market Share by Product in 2018
Table Recombinant Vaccines Price by Product 2014-2019 (USD/Unit)
Table Global Recombinant Vaccines Sales by End User (2014-2019) (K Units)
Table Global Recombinant Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Recombinant Vaccines Market Share by End User (2014-2019)
Figure Global Sales Recombinant Vaccines Market Share by End User in 2018
Figure North America Recombinant Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure North America Recombinant Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Recombinant Vaccines Sales by Countries (2014-2019) (K Units)
Table North America Recombinant Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Recombinant Vaccines Sales Market Share by Countries
Table North America Recombinant Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Recombinant Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Recombinant Vaccines Revenue Market Share by Countries
Figure United States Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure United States Recombinant Vaccines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Canada Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Recombinant Vaccines Sales by Product (2014-2019) (K Units)
Table North America Recombinant Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Recombinant Vaccines Market Share by Product
Table North America Recombinant Vaccines Sales by End User (2014-2019) (K Units)
Table North America Recombinant Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Recombinant Vaccines Market Share by End User
Figure Europe Recombinant Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Europe Recombinant Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Recombinant Vaccines Sales by Countries (2014-2019) (K Units)
Table Europe Recombinant Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Recombinant Vaccines Sales Market Share by Countries
Table Europe Recombinant Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Recombinant Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Recombinant Vaccines Revenue Market Share by Countries
Figure Germany Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Germany Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure France Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure UK Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Italy Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Russia Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Recombinant Vaccines Sales by Product (2014-2019) (K Units)
Table Europe Recombinant Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Recombinant Vaccines Market Share by Product
Table Europe Recombinant Vaccines Sales by End User (2014-2019) (K Units)
Table Europe Recombinant Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Recombinant Vaccines Market Share by End User
Figure Asia Pacific Recombinant Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Recombinant Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Recombinant Vaccines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Recombinant Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Recombinant Vaccines Sales Market Share by Countries
Table Asia Pacific Recombinant Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Recombinant Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Recombinant Vaccines Revenue Market Share by Countries
Figure China Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure China Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Japan Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Korea Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure India Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Australia Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Recombinant Vaccines Sales by Product (2014-2019) (K Units)
Table Asia Pacific Recombinant Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Recombinant Vaccines Market Share by Product
Table Asia Pacific Recombinant Vaccines Sales by End User (2014-2019) (K Units)
Table Asia Pacific Recombinant Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Recombinant Vaccines Market Share by End User
Figure Central & South America Recombinant Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Recombinant Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Recombinant Vaccines Sales by Countries (2014-2019) (K Units)
Table Central & South America Recombinant Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Recombinant Vaccines Sales Market Share by Countries
Table Central & South America Recombinant Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Recombinant Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Recombinant Vaccines Revenue Market Share by Countries
Figure Brazil Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Recombinant Vaccines Sales by Product (2014-2019) (K Units)
Table Central & South America Recombinant Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Recombinant Vaccines Market Share by Product
Table Central & South America Recombinant Vaccines Sales by End User (2014-2019) (K Units)
Table Central & South America Recombinant Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Recombinant Vaccines Market Share by End User
Figure Middle East and Africa Recombinant Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Recombinant Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Recombinant Vaccines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Recombinant Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Recombinant Vaccines Sales Market Share by Countries
Table Middle East and Africa Recombinant Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Recombinant Vaccines Revenue Market Share by Countries
Figure GCC Countries Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Recombinant Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Recombinant Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Vaccines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Recombinant Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Recombinant Vaccines Market Share by Product
Table Middle East and Africa Recombinant Vaccines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Recombinant Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Recombinant Vaccines Market Share by End User
Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co., Inc Recent Development
Table Green Cross Corporation Company Details
Table Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Green Cross Corporation Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. Recent Development
Table Bayer AG Company Details
Table Bayer AG Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Recent Development
Table Sanofi S A. Company Details
Table Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi S A. Recent Development
Table Protein Science Corporation Company Details
Table Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Protein Science Corporation Recent Development
Table GlaxoSmithKline Plc. Company Details
Table GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Bharat Biotech Company Details
Table Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bharat Biotech Recent Development
Table Global Recombinant Vaccines Sales Forecast by Regions 2019-2025 (K Units)
Table Global Recombinant Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Recombinant Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Recombinant Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Recombinant Vaccines Sales Forecast by Product 2019-2025 (K Units)
Table Global Recombinant Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Recombinant Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Recombinant Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Recombinant Vaccines Sales Forecast by End User 2019-2025 (K Units)
Table Global Recombinant Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Recombinant Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Recombinant Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Recombinant Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Recombinant Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Recombinant Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Recombinant Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Recombinant Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Recombinant Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Recombinant Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Recombinant Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Recombinant Vaccines Value Chain
Table Recombinant Vaccines Customers List
Table Recombinant Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Povidone Iodine (PVP Iodine) Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 15-Jul-2019        Price: US 3000 Onwards        Pages: 143
    Povidone Iodine (PVP Iodine) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Povidone Iodine (PVP Iodine) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Povidone Iodine (PVP Iodine) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-202......
  • Nalbuphine HCL Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 15-Jul-2019        Price: US 3000 Onwards        Pages: 135
    Nalbuphine HCL Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nalbuphine HCL industry with a focus on the Chinese market. The report provides key statistics on the market status of the Nalbuphine HCL manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Nalbuphine HCL market......
  • Ion Channel Modulators Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 15-Jul-2019        Price: US 3000 Onwards        Pages: 137
    Ion Channel Modulators Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ion Channel Modulators industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ion Channel Modulators manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chine......
  • Human Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 15-Jul-2019        Price: US 3000 Onwards        Pages: 139
    Human Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Human Vaccine market cov......
  • Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028
    Published: 15-Jul-2019        Price: US 9500 Onwards        Pages: 123
    DelveInsight's ‘Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the emerging market trends of Pompe Disease in the Asia (China and Taiwan), Middle East (Saudi Arabia and U.A.E.), Eastern Europe (Russia and Turkey) and LATAM (Mexico, Brazil, Argentina and Colombia). This Report provides the current treatment practices, emerging drugs, market share of the......
  • Therapeutic Vaccines Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 14-Jul-2019        Price: US 3000 Onwards        Pages: 135
    Therapeutic Vaccines Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Therapeutic Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Therapeutic Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese The......
  • Global Head Lice Infestation Drug Market Research Report 2012-2024
    Published: 14-Jul-2019        Price: US 2050 Onwards        Pages: 78
    Summary Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. The global Head Lice Infestation Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, ......
  • Acetylcysteine Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 13-Jul-2019        Price: US 2280 Onwards        Pages: 68
    According to 99Strategy, the Global Acetylcysteine Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Acetylcysteine market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving indus......
  • Global Furosemide Market Research Report 2012-2024
    Published: 13-Jul-2019        Price: US 3760 Onwards        Pages: 100
    Summary The global Furosemide market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs